8-K
filed May 6, 2026, 7:59 PM ET
ticker TECH
CIK 0000842023
earnings
confidence high
sentiment neutral
materiality 0.60
Bio-Techne Q3 revenue down 2% to $311.4M, adj EPS $0.53; declares $0.08 dividend
BIO-TECHNE Corp
2026-Q3 EPS reported
$0.81
revenue$893,847,000
- Revenue $311.4M, down 2% reported and organic; GAAP EPS $0.32 (up from $0.14), adjusted EPS $0.53 (down from $0.56).
- Large pharma grew double-digits for sixth consecutive quarter; U.S. academic market stabilized with low-single-digit growth; emerging biotech spending still lagging.
- Protein Sciences segment sales $226.2M (down 1% reported); segment margin 44.2% vs 45.6%.
- Diagnostics & Spatial Biology segment sales $85.6M (down 4% reported, up 3% organic); segment margin improved to 12.1% from 9.4%.
- Declared quarterly dividend $0.08 per share, payable May 29, 2026 to shareholders of record May 18, 2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-26-055887
- form_type
- 8-K
- ticker
- TECH
- cik
- 0000842023
- company_name
- BIO-TECHNE Corp
- filed_at
- 2026-05-06T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.810668+00:00
- generated_at
- 2026-05-14T23:04:16.343121+00:00
- sec_items
- ["2.02", "8.01", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-26-055887
- json_url
- https://secwatch.observer/filing/0001104659-26-055887.json
- markdown_url
- https://secwatch.observer/filing/0001104659-26-055887.md
- text_url
- https://secwatch.observer/filing/0001104659-26-055887.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/842023/000110465926055887/0001104659-26-055887-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/842023/000110465926055887/tech-20260506x8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SNDA
Sonida Senior Living reports Q1 net loss of $41.2M; revenue up 37% on CHP acquisition
SONIDA SENIOR LIVING, INC.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.
Filing page
SEC filing
RPC
Ridgepost Capital reports record AUM of $31B in Q1 2026, up 18% YoY
Ridgepost Capital, Inc.
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.
Filing page
SEC filing
IVF
INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
INVO Fertility, Inc.
June 2, 2026, 8:40 AM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
and technologies,
today announced fiscal year 2025 financial results. FY2025
Financial Highlights (all metrics compared to FY2024 unless otherwise noted) ● Revenue
was $6,841,250, an increase of 5% compared to $6,532,000. ● Consolidated
clinic revenue increased 4% to $6,721,057, compared to $6,450,431. ● Revenue
from all clinics was $8,021,929, including
Filing page
SEC filing
POLA
Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%
Polar Power, Inc.
June 2, 2026, 8:30 AM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
Q1 2026 Q1 2025 Y/Y +/(-) Change Net sales $ 1,728 $ 1,723 — Gross profit $ 1,135 $ 320 255 % Gross margin 65.7 % 18.6 % 47.1 pts Total operating expenses $ 1,111 $ 1,421 22 % Income (loss) from operations $ 24 $ (1,101 ) 102 % Net loss $ (178 ) $ (1,265 ) 86 % Net loss per share $ (0.05 ) $ (0.50 ) 90 %
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
(EXHIBIT 99.1) ---
EX-99.1 2 tm2616574d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CITITRENDS ANNOUNCES FIRST QUARTER
FISCAL 2026 RESULTS Q1 2026 total sales increased 14.4% to $230.9 million Comparable store sales growth
of 13.9%; Two-year stack of 23.8% Q1 2026 Net Income of $7.8 million;
Q1 2026 adjusted EBITDA* of $13.9 million, more than double Q1 2025 results
Filing page
SEC filing
DAVEY TREE EXPERT CO
Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M
DAVEY TREE EXPERT CO
June 1, 2026, 1:50 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
Exchange Act, unless such subsequent filing specifically references this Form 8-K.
--- EX-99.1 (EX-99.1) ---
To Our Shareholders, The Company’s first quarter 2026 revenue of $435.8 million increased slightly from the record first quarter 2025 revenue by $1.0 million, or 0.2%. This growth was driven by consistent demand in the Utility segment, where revenue
Filing page
SEC filing
DXYN
Dixie Group Q1 2026 net income $1.4M vs loss of $1.6M YoY; sales down 5.7%
DIXIE GROUP INC
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
2026) -- The Dixie Group, Inc. (OTCQB: DXYN) today reported financial results for the quarter ended March 28, 2026. For the first quarter of 2026, the Company had net sales of $59,380,000 as compared to $62,990,000 in the same quarter of 2025. The Company had an operating income of $3,264,000 in the first quarter of 2026 compared to an operating income of $11,000
Filing page
SEC filing
EXPI
eXp World Holdings Q1 revenue $1.0B (+5% YoY), net loss narrows to $(5.1M), Adj. EBITDA $4.1M (+88%)
eXp World Holdings, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
A copy of the press release issued by Bio-Techne Corporation on May 6, 2026, describing the results of operations for the quarter and nine months ended March 31, 2026, and its financial condition as of March 31, 2026 is attached hereto as Exhibit 99.1.
Comparable filing
the company's scale and our focus on operational efficiency across eXp World Holdings,” said Jesse Hill, Chief Financial Officer of eXp World Holdings. “We generated revenue of $1.0 billion and Adjusted EBITDA of $4.1 million, an 88% improvement that further strengthened our financial position. More recently, we executed the strategic NextHome acquisition using cash
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.